Device Trial Radar · NCT04918680
Prospective Post-market Study Examining the Effectiveness of the EcoFit®
Last checked: Nov 20, 2026Latest source record: Jun 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Jun 21, 2021
Primary completion
Dec 30, 2026
Study completion Mar 30, 2027
Sponsor
- Lead sponsor
- Implantcast North America, LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 9, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and effectiveness of the EcoFit Hip with implacross E polyethylene for total hip replacement surgery.
Conditions
- Degenerative Joint Disease
- Femoral Fracture
- Osteoarthritis, Hip
- Traumatic Arthritis
Interventions
EcoFit® Total Hip System with implacross® E PolyethyleneDevice
The EcoFit® Total Hip System is a primary hip replacement system indicated for patients who are candidates for a primary cementless hip replacement. implacross® E Polyethylene is one of the components in the EcoFit® system.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Survival of the EcoFit Hip with implacross E polyethylene for total hip replacement surgeryTime frame: 36 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.